Global Immunohistochemistry Market by Product (Antibodies, Equipment, Kits), Application (Diagnostics, Drug Testing, Forensic), End-user - Forecast 2024-2030- Product Image

Sale

Global Immunohistochemistry Market by Product (Antibodies, Equipment, Kits), Application (Diagnostics, Drug Testing, Forensic), End-user - Forecast 2024-2030

Report
198 Pages
March 2024
Region: Global
360iResearch™
ID: 5137198

UP TO €850EUR$875USD£733GBP OFF until Dec 31^st 2024

The Immunohistochemistry Market size was estimated at USD 2.58 billion in 2023, USD 2.77 billion in 2024, and is expected to grow at a CAGR of 8.17% to reach USD 4.48 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immunohistochemistry Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunohistochemistry Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immunohistochemistry Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agilent Technologies Inc., Becton, Dickinson & Company, Bio SB, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Biocare Medical LLC, Biogenex Laboratories, CANDOR Bioscience GmbH, Cell Signaling Technology Inc., CellCarta Biosciences Inc., Danaher Corporation, Diagnostic BioSystems Inc., Eagle Biosciences, Inc., Elabscience Biotechnology Inc., F. Hoffman-La Roche AG, Genemed Biotechnologies, Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, PerkinElmer Inc., PHC Holdings Corporation, Rockland Immunochemicals, Inc., Sakura Finetek Japan Co., Ltd., Takara Bio USA, Inc., and Thermofisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Immunohistochemistry Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Antibodies
  - Primary Antibodies
  - Secondary Antibodies
- Equipment
  - Slide Scanners
  - Slide Staining Systems
  - Tissue Microarrays
  - Tissue Processing Systems
- Kits
- Reagents
  - Blocking Sera & Reagents
  - Chromogenic Substrates
  - Diluents
  - Fixation Reagents
  - Histological Stains
  - Organic Solvents
  - Proteolytic Enzymes
  - Stabilizers
Application
- Diagnostics
  - Autoimmune Diseases
  - Cancer
  - Cardiovascular Diseases
  - Diabetes Mellitus
  - Infectious Diseases
  - Nephrological Diseases
- Drug Testing
- Forensic
End-user
- Academic & Research Institutes
- CROs
- Forensic Labs
- Hospitals & Diagnostic Laboratories
- Pharma & Biopharma Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Immunohistochemistry Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunohistochemistry Market?
What are the technology trends and regulatory frameworks in the Immunohistochemistry Market?
What is the market share of the leading vendors in the Immunohistochemistry Market?
Which modes and strategic moves are suitable for entering the Immunohistochemistry Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Immunohistochemistry Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Extensive prevalence of chronic diseases such as cancer and autoimmune diseases among population
5.1.1.2. Development of technologically advanced IHC solutions coupled with rising product approvals
5.1.1.3. Increasing drug discoveries and development activities
5.1.2. Restraints
5.1.2.1. Capital intensive setup and dearth of specificity in IHC solutions
5.1.3. Opportunities
5.1.3.1. Merging collaborations between pharmaceutical companies and players involved in IHC development
5.1.3.2. Growing demand for personalized/customized medicine
5.1.4. Challenges
5.1.4.1. Concerns pertinent to product failure and shortage of skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Immunohistochemistry Market, by Product

6.1. Introduction
6.2. Antibodies
6.3.1. Primary Antibodies
6.3.2. Secondary Antibodies
6.3. Equipment
6.4.1. Slide Scanners
6.4.2. Slide Staining Systems
6.4.3. Tissue Microarrays
6.4.4. Tissue Processing Systems
6.4. Kits
6.5. Reagents
6.6.1. Blocking Sera & Reagents
6.6.2. Chromogenic Substrates
6.6.3. Diluents
6.6.4. Fixation Reagents
6.6.5. Histological Stains
6.6.6. Organic Solvents
6.6.7. Proteolytic Enzymes
6.6.8. Stabilizers

7. Immunohistochemistry Market, by Application

7.1. Introduction
7.2. Diagnostics
7.3.1. Autoimmune Diseases
7.3.2. Cancer
7.3.3. Cardiovascular Diseases
7.3.4. Diabetes Mellitus
7.3.5. Infectious Diseases
7.3.6. Nephrological Diseases
7.3. Drug Testing
7.4. Forensic

8. Immunohistochemistry Market, by End-user

8.1. Introduction
8.2. Academic & Research Institutes
8.3. CROs
8.4. Forensic Labs
8.5. Hospitals & Diagnostic Laboratories
8.6. Pharma & Biopharma Companies

9. Americas Immunohistochemistry Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Immunohistochemistry Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Immunohistochemistry Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Abcam PLC
13.1.2. Agilent Technologies Inc.
13.1.3. Becton, Dickinson & Company
13.1.4. Bio SB
13.1.5. Bio-Rad Laboratories Inc.
13.1.6. Bio-Techne Corporation
13.1.7. Biocare Medical LLC
13.1.8. Biogenex Laboratories
13.1.9. CANDOR Bioscience GmbH
13.1.10. Cell Signaling Technology Inc.
13.1.11. CellCarta Biosciences Inc.
13.1.12. Danaher Corporation
13.1.13. Diagnostic BioSystems Inc.
13.1.14. Eagle Biosciences, Inc.
13.1.15. Elabscience Biotechnology Inc.
13.1.16. F. Hoffman-La Roche AG
13.1.17. Genemed Biotechnologies, Inc.
13.1.18. Merck KGaA
13.1.19. Miltenyi Biotec B.V. & Co. KG
13.1.20. PerkinElmer Inc.
13.1.21. PHC Holdings Corporation
13.1.22. Rockland Immunochemicals, Inc.
13.1.23. Sakura Finetek Japan Co., Ltd.
13.1.24. Takara Bio USA, Inc.
13.1.25. Thermofisher Scientific, Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. IMMUNOHISTOCHEMISTRY MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOHISTOCHEMISTRY MARKET SIZE, 2023 VS 2030
FIGURE 3. IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNOHISTOCHEMISTRY MARKET DYNAMICS
FIGURE 7. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. IMMUNOHISTOCHEMISTRY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. IMMUNOHISTOCHEMISTRY MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. IMMUNOHISTOCHEMISTRY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 8. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 12. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 19. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 30. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 68. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 69. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 70. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 72. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 75. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 76. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 105. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 106. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 107. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 109. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 112. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 113. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 114. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 116. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 126. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 127. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 128. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 130. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 140. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 141. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 142. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 147. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 148. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 149. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 151. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 154. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 155. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 156. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 161. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 162. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 163. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 165. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 168. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 169. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 170. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 172. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 175. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 176. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 177. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 179. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 188. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 190. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 191. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 192. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 194. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 197. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 198. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 199. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 201. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 204. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 205. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 206. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 211. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 212. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 213. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 215. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 218. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 219. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 220. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 222. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 225. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 226. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 227. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 232. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 233. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 234. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 236. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 253. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 254. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 255. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 257. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 260. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 261. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 262. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 264. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 266. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 267. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 268. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 269. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 271. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 293. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 294. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 295. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 296. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 297. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 299. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 307. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 308. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 309. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 310. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 311. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 313. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 314. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 315. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 316. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 317. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 318. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 320. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 328. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 330. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 332. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 334. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 335. IMMUNOHISTOCHEMISTRY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 336. IMMUNOHISTOCHEMISTRY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 337. IMMUNOHISTOCHEMISTRY MARKET LICENSE & PRICING

Companies Mentioned

Abcam PLC
Agilent Technologies Inc.
Becton, Dickinson & Company
Bio SB
Bio-Rad Laboratories Inc.
Bio-Techne Corporation
Biocare Medical LLC
Biogenex Laboratories
CANDOR Bioscience GmbH
Cell Signaling Technology Inc.
CellCarta Biosciences Inc.
Danaher Corporation
Diagnostic BioSystems Inc.
Eagle Biosciences, Inc.
Elabscience Biotechnology Inc.
F. Hoffman-La Roche AG
Genemed Biotechnologies, Inc.
Merck KGaA
Miltenyi Biotec B.V. & Co. KG
PerkinElmer Inc.
PHC Holdings Corporation
Rockland Immunochemicals, Inc.
Sakura Finetek Japan Co., Ltd.
Takara Bio USA, Inc.
Thermofisher Scientific, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	198
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.77 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.48 Billion
Compound Annual Growth Rate	8.1%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3277EUR$3,374USD£2,827GBP €3641EUR$3,749USD£3,141GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4151EUR$4,274USD£3,581GBP €4613EUR$4,749USD£3,979GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5025EUR$5,174USD£4,335GBP €5584EUR$5,749USD£4,817GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5900EUR$6,074USD£5,089GBP €6555EUR$6,749USD£5,655GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7648EUR$7,874USD£6,598GBP €8498EUR$8,749USD£7,331GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Immunohistochemistry Market Size, Share & Trends Analysis Report By Product (Antibodies, Reagents, Kits), By Application (Diagnostics, Research), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Global Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End-users (Diagnostic laboratories, Research Institute), and Region - Forecast to 2028

Immunohistochemistry Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

Immunohistochemistry (IHC) Global Market Report 2024

Immunohistochemistry - Global Strategic Business Report